SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-17-015313
Filing Date
2017-03-09
Accepted
2017-03-09 06:04:41
Documents
4
Period of Report
2017-03-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a17-7791_18k.htm 8-K 42005
2 EX-10.1 a17-7791_1ex10d1.htm EX-10.1 1318519
3 EX-10.2 a17-7791_1ex10d2.htm EX-10.2 850439
4 EX-10.3 a17-7791_1ex10d3.htm EX-10.3 320896
  Complete submission text file 0001104659-17-015313.txt   2533099
Mailing Address 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591
Business Address 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 9143477000
REGENERON PHARMACEUTICALS INC (Filer) CIK: 0000872589 (see all company filings)

IRS No.: 133444607 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19034 | Film No.: 17676701
SIC: 2834 Pharmaceutical Preparations